Efficacy of Therapeutic Percutaneous Electrolysis Simple vs Multifiliar Therapy in Supraspinatus Tendinopathy.

Recruiting N/A Interventional Study
Tendinopathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Universidad Pontificia de Salamanca · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Supraspinatus tendinopathy (SE) is one of the main pathologies that cause functional alterations in the glenohumeral joint. It reduces the quality of life of the population suffering from this injury. This pathology is the most frequent cause of pain in this joint. Symptoms are aggravated by repetitive work performed at or above shoulder height and sports that involve movements above the head. Si…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Signing of informed consent both to participate in the study and to undergo invasive physiotherapy techniques. * Presence of symptoms (inflammation or pain) ≥ 4 weeks. * Positive palpation test of the supraspinatus tendon. * Men and women over 18 years of age. * Score of 3 or …
Contacts

Jorge V Velázquez Saornil, PhD.

920277000

jvelazquezsa@upsa.es

CONTACT

Jorge Velázquez Saornil, PhD.

655909940

jvelazquezsa@upsa.es

CONTACT